The global automated endoscopy reprocessor market size was valued at US$ 845.3 million in 2017 and is expected to witness a robust CAGR of 6.7% over the forecast period (2018–2026).
Strategic collaboration to develop advance smart card technology to provide value added services in healthcare is expected propel growth of the market.
Increasing number of samples to be analyzed is increasing the demand for faster analytical methods that are capable of providing better information for decision making.
Drug resistance to antifungal medications is widely witnessed during treatment of aspergillosis infections, which is expected to restrain growth of the acute invasive aspergillosis treatment market
lack of proper reimbursement for the orthodontic procedures and products due to limited insurance coverage is expected to hamper growth of dental braces market
Increasing prevalence of naïve infectious chronic diseases such as chronic kidney disease around the globe is the major factor propelling demand for medical membrane.